News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Oil futures topped $100 after the U.S. announced a naval blockade threat and Iran warned of retaliatory moves, lifting crude prices sharply.
  • Major European benchmarks closed lower as sector losses in autos, telecoms and consumer names outweighed gains.
  • LVMH reported Q1 revenue below estimates as Fashion & Leather Goods lagged, pressuring luxury-sector earnings.
  • IMF-World Bank spring meetings prioritize emerging-market financing amid the Iran war and rising global borrowing costs.
  • US existing home sales fell 3.6% in March, lifting months' supply to its highest level since April 2016.
  • Several companies pushed ahead with US IPO roadshows despite geopolitical tensions, signaling dormant supply awaiting market stability.

Latest Articles

LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

LB Pharmaceuticals reported positive results from Phase 2 trials of LB-102 in schizophrenia, initiated pivotal Phase 3 and additional Phase 2 trials for bipolar depression and major depressive disorder, and announced a $100 million private placement. The company has a strong cash position of $295.2 million as of December 31, 2025, providing a runwa…

Alpine Income Property Trust Announces First Quarter 2026 Earnings Release and Conference Call Information

Alpine Income Property Trust Announces First Quarter 2026 Earnings Release and Conference Call Information

Alpine Income Property Trust, Inc., a publicly traded REIT focusing on single tenant net leased commercial properties and commercial loan investments, announced it will release its Q1 2026 financial results after market close on April 23, 2026, followed by a conference call on April 24, 2026. The company aims to provide updates on its portfolio and…

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights

Arcadia Biosciences announced its financial results for Q4 and full year 2025, reporting a 17% increase in Zola coconut water revenues and significant reductions in SG&A expenses and net cash used in operations. The company also disclosed the termination of a proposed business combination with Roosevelt Resources and the exercise of preferred inves…

Xanadu Quantum Technologies Limited Announces Closing of Business Combination with Crane Harbor Acquisition Corp. and Xanadu Quantum Technologies Inc.

Xanadu Quantum Technologies Limited Announces Closing of Business Combination with Crane Harbor Acquisition Corp. and Xanadu Quantum Technologies Inc.

Xanadu Quantum Technologies Limited has successfully closed its business combination with Crane Harbor Acquisition Corp., a publicly traded SPAC, along with a $275 million PIPE financing. The company will begin trading on Nasdaq and the Toronto Stock Exchange on March 27, 2026, under the ticker symbol XNDU. Xanadu positions itself as the first pure…

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

Crinetics Pharmaceuticals has submitted a Marketing Authorization Application to Brazil's ANVISA for Palsonify (paltusotine), the first once-daily oral therapy approved in the US for acromegaly. The submission follows positive Phase 3 trial results demonstrating efficacy and tolerability and complements recent regulatory progress in Europe. This ma…

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Kyverna Therapeutics reported significant progress in its autoimmune CAR T therapy pipeline, particularly with miv-cel (KYV-101) showing positive clinical results in stiff person syndrome (SPS), generalized myasthenia gravis (gMG), and progressive multiple sclerosis. The company plans a Biologics License Application (BLA) submission for SPS in the …

Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock

Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock

Zenas BioPharma has commenced underwritten public offerings of convertible senior notes due 2032 and common stock. The company plans to use net proceeds to support the U.S. commercial launch of obexelimab, advance its clinical development pipeline including Phase 3 trials of orelabrutinib, and for general corporate purposes. The offerings are subje…

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million

Apogee Therapeutics, a Nasdaq-listed clinical-stage biotech company, successfully closed its underwritten public offering, raising approximately $403 million. The offering included 5,750,000 shares sold at $70 each and full exercise of underwriters' options. Proceeds will support the company’s development of novel biologics targeting inflammatory a…

SIGA Declares Special Cash Dividend of $0.60 Per Share

SIGA Declares Special Cash Dividend of $0.60 Per Share

SIGA Technologies declared a special cash dividend of $0.60 per share payable on April 23, 2026. This dividend demonstrates SIGA's strong financial position and commitment to rewarding shareholders while continuing its work in biodefense, especially smallpox preparedness amid geopolitical uncertainties.

Global Stocks Slide as Brent Hits $108 on Escalating Iran Conflict

Global Stocks Slide as Brent Hits $108 on Escalating Iran Conflict

Stock indexes tumbled and global bond markets sold off on March 26 as a near-month-long conflict in the Middle East rekindled fears of prolonged disruption to oil and gas flows. Brent crude spiked to $108.01 a barrel while safe-haven demand pushed the U.S. dollar higher and gold lower. Market participants reacted to statements from Iranian and U.S.…

Data Centers Asked to Trim Consumption as U.S. Grid Faces Peak Stress

Data Centers Asked to Trim Consumption as U.S. Grid Faces Peak Stress

As electricity demand strains U.S. grids, technology firms are being pressed to adopt flexibility measures that allow data centers to reduce load during peak periods. Utilities, grid operators and investors are testing ways to temporarily shift or trim server workloads, use backup generation, or relocate energy-intensive processing across sites. Th…

EU Accuses Pornhub, Stripchat, XNXX and XVideos of Allowing Underage Access, Cites Digital Services Act Breaches

EU Accuses Pornhub, Stripchat, XNXX and XVideos of Allowing Underage Access, Cites Digital Services Act Breaches

The European Commission has provisionally charged four major adult content platforms - Pornhub, Stripchat, XNXX and XVideos - with breaching the EU's Digital Services Act after a 10-month probe found shortcomings in measures to prevent children accessing pornographic material. Regulators faulted the platforms for relying on weak self-declaration an…

Oil Majors Poised to Pocket Billions as Iran Conflict Sends Prices Soaring

Oil Majors Poised to Pocket Billions as Iran Conflict Sends Prices Soaring

Since the Iran conflict began on February 28, global energy prices have climbed sharply, and the resulting pull of supply through the Strait of Hormuz has stopped roughly one-fifth of worldwide flows. Benchmark Brent averaged about $97 per barrel in March, up from $69 in February and $65 in January. That surge is expected to boost revenues and lift…